LSN3353871
LSN3353871 is a potent inhibitor of lipoprotein (a) (Lp (a) ) that can binds to Kringle IV (KIV) 8, KIV7-8 and KIV5-8, with Kd of 756 nM, 605 nM and 423 nM, respectively. LSN3353871 disrupts the formation of Lp (a) with the IC50 of 1.69 μM. LSN3353871 has oral bioactivity[1].
Product Specifications
CAS Number
2565657-20-5
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/lsn3353871.html
Purity
99.62
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC([C@@H](CC1=CC=CC=C1)[C@@H]2CNCC2)=O.Cl
Molecular Formula
C13H18ClNO2
Molecular Weight
255.74
References & Citations
[1]Nuria Diaz, et al. Discovery of potent small-molecule inhibitors of lipoprotein (a) formation. Nature. 2024 May;629 (8013) :945-950.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD8b, Mouse (H35-17.2), CF640R conjugate, 0.1mg/mL
